PT Medikaloka Hermina Tbk (IDX:HEAL)
760.00
-10.00 (-1.30%)
Aug 12, 2026, 4:14 PM WIB
PT Medikaloka Hermina Tbk Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PT Medikaloka Hermina Tbk stock has a consensus rating of "Buy" and an average price target of Rp 1,436. The average 1-year stock price forecast is 88.96% higher than the current stock price, while the lowest is Rp 950.00 (+25.00%) and the highest is Rp 1,800 (+136.84%).
Price Target: Rp 1,436 (+88.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PT Medikaloka Hermina Tbk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 5 | 7 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 13 | 14 |
Financial Forecast
Revenue This Year
7.74T
from 7.13T
Increased by 8.54%
Revenue Next Year
8.54T
from 7.74T
Increased by 10.27%
EPS This Year
30.21
from 28.40
Increased by 6.36%
EPS Next Year
39.71
from 30.21
Increased by 31.47%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is IDR.